Cost analysis of infusion versus injection delivery of imipenem/cilastatin and meropenem

Clinical Drug Investigation

Volumn 14, Issue 2, 1997, Pages 132-136

  Plumridge, Richard J ^a  

^a Fremantle Hospital and Health Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CILASTATIN PLUS IMIPENEM; MEROPENEM;

ARTICLE; DRUG COST; DRUG DELIVERY SYSTEM; DRUG INFUSION; DRUG MONITORING; ECONOMIC ASPECT; HEALTH CARE COST; HOSPITAL; HUMAN; INJECTION; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL DECISION MAKING; NURSING; PRIORITY JOURNAL; SALARY; STATISTICAL ANALYSIS; TIME;

EID: 0030818370     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199714020-00007     Document Type: Article

References (8)

1. Wiseman LR, Wagstaff AJ, Brogden RN, et al. Meropenem: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 1945; 50: 73-101
2. Thomas J, editor. Australian Prescription Products Guide 1997. 26th ed. Melbourne. Australian Pharmaceutical Publishing Company, 2096-9
3. Thomas J, editor. Australian Prescription Products Guide 1997. 26th ed. Melbourne: Australian Pharmaceutical Publishing Company, 1597-9
4. Roberts MJ. Work measurement. In: Brown TR, Smith MC, editors. Handbook of institutional pharmacy practice. 2nd ed. Baltimore: Williams & Wilkins: 1986: 90-110
5. Plumridge RJ. Cost comparison of intravenous antibiotic administration. Med J Aust 1990; 153: 516-8
6. Gladen HE, Jackson JD, Jordon JT. Antibiotics, DRGs, and the personal computer: simple techniques to estimate true cost. Infect Surg 1986; 5: 559-67
7. Gladen HE. Computer modelling antibiotic therapy costs: impact of therapeutic range. Drugs 1988; 35 Suppl. 2: 208-13
8. Alkinson HC, Chambers ST, McGinlay AM. Antibiotic therapy costs. NZ Med J 1989; 102: 409-11